Perrone, Elisabetta
Perrone, Elisabetta
PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application—A Literature Review
2023 Taralli, Silvia; Lorusso, Maria Luisa; Perrone, Elisabetta; Perotti, Germano; Zagaria, Luca; Calcagni, Maria Lucia
Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients
2022 Buttarelli, M.; Ciucci, A.; Palluzzi, F.; Raspaglio, G.; Marchetti, C.; Perrone, E.; Minucci, A.; Giaco, L.; Fagotti, A.; Scambia, G.; Gallo, D.
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus
2022 Guarneri, Andrea; Perrone, Elisabetta; Bosello, Silvia Laura; D'Agostino, Maria Antonietta; Leccisotti, Lucia
A Multicentric Randomized Trial to Evaluate the ROle of Uterine MANipulator on Laparoscopic/Robotic HYsterectomy for the Treatment of Early-Stage Endometrial Cancer: The ROMANHY Trial
2021 Gueli Alletti, S.; Perrone, E.; Fedele, C.; Cianci, S.; Pasciuto, T.; Chiantera, V.; Uccella, S.; Ercoli, A.; Vizzielli, G.; Fagotti, A.; Gallotta, V.; Cosentino, F.; Costantini, B.; Restaino, S.; Monterossi, G.; Rosati, A.; Turco, L. C.; Capozzi, V. A.; Fanfani, F.; Scambia, G.
Laparoscopic vs. Robotic-assisted laparoscopy in endometrial cancer staging: Large retrospective single-institution study
2021 Perrone, E.; Capasso, I.; Pasciuto, T.; Gioe, A.; Gueli Alletti, S.; Restaino, S.; Scambia, G.; Fanfani, F.
Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer
2020 Perrone, E.; Lopez, S.; Zeybek, B.; Bellone, S.; Bonazzoli, E.; Pelligra, S.; Zammataro, L.; Manzano, A.; Manara, P.; Bianchi, A.; Buza, N.; Tymon-Rosario, J.; Altwerger, G.; Han, C.; Menderes, G.; Ratner, E.; Silasi, D. -A.; Azodi, M.; Hui, P.; Schwartz, P. E.; Scambia, G.; Santin, A. D.
Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo
2020 Perrone, E.; Manara, P.; Lopez, S.; Bellone, S.; Bonazzoli, E.; Manzano, A.; Zammataro, L.; Bianchi, A.; Zeybek, B.; Buza, N.; Tymon-Rosario, J.; Altwerger, G.; Han, C.; Menderes, G.; Huang, G. S.; Ratner, E.; Silasi, D. -A.; Azodi, M.; Hui, P.; Schwartz, P. E.; Scambia, G.; Santin, A. D.
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2023 | PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application—A Literature Review | Taralli, Silvia; Lorusso, Maria Luisa; Perrone, Elisabetta; Perotti, Germano; Zagaria, Luca; Calcagni, Maria Lucia | |
| 1-gen-2022 | Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients | Buttarelli, M.; Ciucci, A.; Palluzzi, F.; Raspaglio, G.; Marchetti, C.; Perrone, E.; Minucci, A.; Giaco, L.; Fagotti, A.; Scambia, G.; Gallo, D. | |
| 1-gen-2022 | The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus | Guarneri, Andrea; Perrone, Elisabetta; Bosello, Silvia Laura; D'Agostino, Maria Antonietta; Leccisotti, Lucia | |
| 1-gen-2021 | A Multicentric Randomized Trial to Evaluate the ROle of Uterine MANipulator on Laparoscopic/Robotic HYsterectomy for the Treatment of Early-Stage Endometrial Cancer: The ROMANHY Trial | Gueli Alletti, S.; Perrone, E.; Fedele, C.; Cianci, S.; Pasciuto, T.; Chiantera, V.; Uccella, S.; Ercoli, A.; Vizzielli, G.; Fagotti, A.; Gallotta, V.; Cosentino, F.; Costantini, B.; Restaino, S.; Monterossi, G.; Rosati, A.; Turco, L. C.; Capozzi, V. A.; Fanfani, F.; Scambia, G. | |
| 1-gen-2021 | Laparoscopic vs. Robotic-assisted laparoscopy in endometrial cancer staging: Large retrospective single-institution study | Perrone, E.; Capasso, I.; Pasciuto, T.; Gioe, A.; Gueli Alletti, S.; Restaino, S.; Scambia, G.; Fanfani, F. | |
| 1-gen-2020 | Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer | Perrone, E.; Lopez, S.; Zeybek, B.; Bellone, S.; Bonazzoli, E.; Pelligra, S.; Zammataro, L.; Manzano, A.; Manara, P.; Bianchi, A.; Buza, N.; Tymon-Rosario, J.; Altwerger, G.; Han, C.; Menderes, G.; Ratner, E.; Silasi, D. -A.; Azodi, M.; Hui, P.; Schwartz, P. E.; Scambia, G.; Santin, A. D. | |
| 1-gen-2020 | Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo | Perrone, E.; Manara, P.; Lopez, S.; Bellone, S.; Bonazzoli, E.; Manzano, A.; Zammataro, L.; Bianchi, A.; Zeybek, B.; Buza, N.; Tymon-Rosario, J.; Altwerger, G.; Han, C.; Menderes, G.; Huang, G. S.; Ratner, E.; Silasi, D. -A.; Azodi, M.; Hui, P.; Schwartz, P. E.; Scambia, G.; Santin, A. D. |